ArticleNanomedicine (London, England)2025

Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma.

Monica Mossenta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.